28th June 2013 | Established with the capital of 20,000,000 yen |
24th July 2013 | Applied Patent 1: Therapeutic drug and therapeutic method for neurological diseases including Alzheimer’s disease associated with 1,25 D3-MARRS |
21st Apr 2015 | Applied Patent 2: Therapeutic agent for diseases associated with nerve axon dysfunction, including therapeutic agent for Alzheimer’s disease |
30th June 2015 | As a division of Patent 1: Resilio applied for patent 3 that Diosgenin, 1,25 D3-MARRS etc., has effect on various neurological diseases through food and drink supplements and additives |
7th Aug 2015 | Registered Patent 1, Registration Number : 5789339 |
Jan 2016 | Commence the double-blind crossover clinical trial of Diosgenin |
8th June 2016 | The capital increased to 27,000,000 yen through increase in shareholder allocation |
18th Aug 2016 | Applied Patent 4: ActivatIng agent for reconstitution of the neural network |
Nov 2016 | Completion of the clinical trial |
Feb 2017 | Completion of analysis with the clinical trial results |
30th June 2017 | Registered Patent 2, Registration Number : 6165323 |
30th June 2017 | Registered Patent 4, Registration Number : 6165380 |
29th Sep 2017 | The capital increased to 39,600,000 yen through increase in third-party allocation. |
5th Jan 2018 | Registered Patent 3, Registration Number : 6267160 |
18th Jan 2018 | Received the patent objection(2018-700039) against the Patent 2, Already submitted the reasoned comments |
18th Apr 2018 | The office established at the current address |
April 2018 | Clinical research summary with Diosgenin in Yam contributed at the monthly journal ”Gekkan Kenko vol.April” published by Shufunotomo-sha |
Aug 2018 | The article titled“ The Secret of Prevention and Treatment for Dementia” based on the clinical research with Diosgenin in Yam, contributed at the monthly journal ”Soukai vol.August” published by Makino-Shuppan |
Oct 2018 | The article titled“ Series of Dementia, Look at this Person” based on the clinical research with Diosgenin in Yam, contributed at the monthly journal ”Kenko 365 vol.October 2018” published by H&I inc |
Nov 2018 | Our supplement ”Diosgenin Gold” started marketing in Japan. |
Jul 2019 | Solved the patent objection issue(2018-700039) against the Patent 2, Maintenance of the Patent 2(6165323) decided |
sokai kenko365 Gekkan Kenko